Børsen
The battle between Pfizer and Novo Nordisk over the biotech company Metsera is escalating. Pfizer’s CEO believes that Novo Nordisk is attempting to eliminate a new competitor with its acquisition offer.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?